
Brush up your geographic atrophy knowledge with our 2024 content highlights.

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM.

Tenpoint Therapeutics and Visus Therapeutics have merged to focus on aging-related ocular conditions, with key products including BRIMOCHOL PF for presbyopia and therapies for cataracts and geographic atrophy.

Inside the role of blepharitis in ocular surface disease and effective management strategies.

The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children.

How to be optimistic, responsible, and open in the face of new technology.

The study evaluates Duravyu’s efficacy, durability, and re-dosing every 6 months in both treatment-naïve and previously treated patients.

The ELIOS system is a laser-based technology that offers a new approach to treating glaucoma, particularly in conjunction with cataract surgery.

All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.

The company begins phase 1 trials of oral GAL-101, targeting amyloid beta aggregation for potential treatment of dry AMD, glaucoma, and neurodegenerative eye diseases.

The trial is expected to close randomization in early December 2024.

New long-term findings illuminate the future of DIMS spectacle lenses.

Catch up on what happened in optometry during the week of December 2-December 6.

The study found that the prosthetic replacement of the ocular surface ecosystem lenses were well tolerated in the delivery of non-preserved cyclosporine 0.05%.

Relapse and chronic uveitis can occur after infectious uveitis was treated successfully, study authors found.

In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.

Tiffany Tsoi, OD, FAAO, shares insights on the world of visual training research for eSports athletes.

Watching out for inevitable degenerative changes can improve patient care.


The primary findings were that a higher BMI was protective against glaucoma progression and use of tobacco and alcohol were not significantly associated with retinal nerve fiber layer change.

The retrospective study investigated and analyzed the severity and frequency of ocular pain and factors affecting it among DED patients living in high altitudes above 2500 meters during the COVID-19 pandemic.

The organization will provide resources for spreading awareness and educating patients and care givers.

Studies point to an inverse association between diabetes and keratoconus risk.

Catch up on what happened in optometry during the week of November 25-November 29.

Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.

AOA members can receive a $1500 Visa gift card after signing up with Barti and being live on the platform for 3 months.

Optometric insights shine brighter than the lights on the Las Vegas Strip.

Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been recommending the NutriTears supplement to their dry eye patients.

Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.